At twelve months of age, TgAD rats have more extensive cognitive decline, increased Aβ plaques, cerebral amyloid angiopathy, and exhibit significant tau inclusions representing established disease20. The gene discussed is MAPT; the disease is cerebral amyloid angiopathy.